BPC-157

Overview

BPC-157 (Body Protection Compound-157) is a 15-amino acid synthetic peptide derived from a protective protein found in human gastric juice. It is one of the most widely studied peptides in the regenerative research space, with a broad literature base spanning musculoskeletal, gastrointestinal, and neurological models.

Mechanism of Action

BPC-157 promotes angiogenesis through upregulation of VEGF (vascular endothelial growth factor) and modulates the nitric oxide (NO) system. It supports the FAK-paxillin pathway involved in cell migration and wound closure. Additional research suggests interaction with the dopaminergic, serotonergic, and GABAergic systems, indicating effects beyond simple tissue repair.

Research Context

Animal model studies have demonstrated accelerated healing of tendons, ligaments, muscles, bones, and intestinal tissue following BPC-157 administration. Gastric protection studies show cytoprotective effects against NSAID-induced lesions, alcohol damage, and stress ulcers. Neurological research has explored its potential in models of traumatic brain injury and peripheral nerve damage.

Key Research Areas

Considerations for Researchers

BPC-157 is available in both injectable and oral (tablet/capsule) forms. The peptide is remarkably stable in gastric acid, supporting oral bioavailability research. Standard reconstitution with BAC water for injectable preparations. Verify purity via HPLC and confirm sequence via mass spec.